Clinical Trial Update: Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Nab-paclitaxel with gemcitabine to gemcitabine with tegafur as adjuvant therapy after radical resection of pancreatic cancer; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Nab-paclitaxel + gemcitabine
• gemcitabine + tegafur

Snippet

Sponsor: Fudan University | Conditions: Stage IA Pancreatic Adenocarcinoma, Stage IB Pancreatic Adenocarcinoma | Phase 2 | Status: UNKNOWN